![]() |
市場調查報告書
商品編碼
1700020
2032 年對氨基苯酚預測:按形態、等級、銷售管道、應用和地區進行的全球分析Para Aminophenol Market Forecasts to 2032 - Global Analysis By Form (Powder, Crystals, and Liquids), Grade, Sales Channel, Application and By Geography |
根據 Stratistics MRC 的數據,全球對氨基苯酚市場預計在 2025 年達到 30.1 億美元,到 2032 年將達到 46.3 億美元,預測期內的複合年成長率為 6.3%。
對氨基苯酚(PAP)是一種有機化合物,化學式為C6H7NO。它是一種結晶質固體,主要用於製造乙醯胺酚(乙醯胺酚),一種常見的止痛藥和退燒藥。 PAP也用於製造染料和顏料,特別是在紡織業中,以及製造用於攝影和影像處理的化學品。由於其用途廣泛,包括藥品、化學品和化妝品,它是各種行業的重要原料。
對乙醯胺酚的需求不斷增加
對乙醯胺酚,也稱為乙醯胺酚,是一種常用的非處方止痛退燒藥。對乙醯胺酚的需求是由於慢性疾病和與疼痛管理相關的病症(例如關節炎和術後疼痛)的發病率不斷上升所致。隨著人口老化和對疼痛管理方法的了解不斷加深,對乙醯胺酚的消費量也增加。全球約 80% 的 PAP 產量由對乙醯胺酚製成,因此對乙醯胺酚市場直接影響 PAP 需求。
原物料價格波動
原物料價格波動是對氨基苯酚(PAP)市場的主要限制因素。這是因為苯胺和其他化學前驅等關鍵投入的成本波動直接影響生產成本。價格波動為製造商帶來了不確定性,影響了他們維持一致定價策略的能力。這種不可預測性也可能迫使公司調整利潤率、提高產品價格並推遲生產計劃。此外,對不同經濟狀況地區供應商的依賴進一步加劇了挑戰,使企業難以長期有效地規劃和管理生產成本。
製藥業的擴張
對乙醯胺酚(乙醯胺酚)等非處方藥的需求不斷增加,而這些藥物是由 PAP 生產的,這是由於全球(尤其是新興國家)的醫療保健需求不斷成長。解熱鎮痛療法的日益普及進一步推動了製藥製造業對 PAP 的需求。隨著醫療保健基礎設施的發展和藥品的普及,開發中國家對 PAP 的使用也增加。預計此類擴張將支持 PAP 市場製藥領域的持續成長。
供應鏈中斷
由於供應鏈中斷,對氨基苯酚 (PAP) 市場面臨重大挑戰。供應鏈中斷可能會損害原料的可得性、推遲生產計劃並影響分銷網路。新冠肺炎疫情、自然災害和地緣政治緊張局勢等疫情可能會導致必需化學品前驅物和最終產品的運輸延誤。這些中斷將導致前置作業時間增加、營運成本上升,甚至可能導致市場上的產品減少。此外,製造商可能難以以可負擔的成本找到可靠的原料來源,這可能會影響他們滿足需求和維持利潤的能力。
COVID-19 疫情導致供應鏈延遲、生產設施暫時關閉,影響了對氨基苯酚 (PAP) 市場,影響了產量。然而,隨著人們尋求非處方藥來減輕發燒和疼痛,對藥物 PAP(特別是對乙醯胺酚(乙醯胺酚))的需求激增。儘管製藥業表現出韌性,但紡織和染料產業面臨放緩。預計疫情後的復甦將推動 PAP 市場穩定成長。
電子商務領域預計將成為預測期內最大的領域
由於製造商和供應商更容易獲得原料,預計電子商務領域將在預測期內佔據最大的市場佔有率。這個線上平台為企業提供了一種便捷的方式來採購用於製藥、化學和化妝品應用的 PAP。電子商務還透過促進直接貿易、降低分銷成本和擴大客戶範圍來提高市場准入度,特別是對於中小型企業而言,從而促進 PAP 行業的整體成長。
預計在預測期內,製藥業將實現最高的複合年成長率。
由於對乙醯胺酚(乙醯胺酚)的需求不斷增加,預計預測期內製藥業將出現最高成長率,乙醯氨基酚被廣泛用於止痛藥和退燒藥。隨著全球尤其是新興市場的醫療保健需求不斷成長,用於生產止痛藥的 PAP 的需求也日益增加。此外,醫療保健基礎設施的進步和非處方藥取得管道的增加進一步推動了製藥業對 PAP 的需求。
在預測期內,由於工業化快速發展、製藥生產擴張以及紡織和化妝品行業的擴張,預計亞太地區將佔據最大的市場佔有率。中國和印度等國家對乙醯胺酚的需求不斷增加將促進製藥業的發展,而染料和顏料中 PAP 的使用量不斷增加將支持紡織和個人護理行業的發展。此外,具有成本效益的製造和龐大的消費群也促進了該地區 PAP 市場的強勁成長。
預計北美地區在預測期內將呈現最高的複合年成長率。這是由於對止痛藥和退燒藥的需求不斷成長,推動了 PAP 的消費。此外,北美成熟的製藥業將有助於市場擴張,而紡織品和化妝品對高級染料的需求不斷成長將進一步推動成長。這一趨勢正在加強該地區在全球 PAP 市場的影響力。
According to Stratistics MRC, the Global Para Aminophenol Market is accounted for $3.01 billion in 2025 and is expected to reach $4.63 billion by 2032 growing at a CAGR of 6.3% during the forecast period. Para-Aminophenol (PAP) is an organic compound with the chemical formula C6H7NO. It is a crystalline solid primarily used in the production of acetaminophen (paracetamol), a common analgesic and antipyretic. PAP is also employed in the manufacturing of dyes and pigments, especially in the textile industry, and in the production of certain chemicals used in photography and imaging. Its versatile applications in pharmaceuticals, chemicals, and cosmetics make it a critical raw material in various industries.
Growing demand for acetaminophen
Acetaminophen, also known as paracetamol, is widely used as an over-the-counter medication for pain relief and fever reduction. The need for acetaminophen is being driven by the rising incidence of chronic illnesses and pain-management-related ailments such arthritis and post-operative pain. Increased acetaminophen consumption is also a result of the aging population and growing understanding of pain management options. Since acetaminophen is made from roughly 80% of PAP produced worldwide, the market for acetaminophen has a direct impact on PAP demand.
Volatility in raw material prices
Volatility in raw material prices is a significant restraint for the Para-Aminophenol (PAP) market, as fluctuations in the cost of key inputs, such as aniline and other chemical precursors, directly affect production costs. Price instability can lead to uncertainty for manufacturers, impacting their ability to maintain consistent pricing strategies. This unpredictability may also force companies to adjust their profit margins, increase product prices, or delay production schedules. Additionally, reliance on suppliers from different regions, with varying economic conditions, further exacerbates the challenge, making it difficult for companies to plan and manage production costs effectively in the long term.
Expansion of pharmaceutical industry
The increased demand for over-the-counter drugs like acetaminophen (paracetamol), which is produced from PAP, is a result of the growing healthcare demands worldwide, especially in emerging nations. The necessity for PAP in pharmaceutical manufacture is further increased by the rising popularity of fever-reducing and pain-management therapies. PAP use is also increased in developing nations due to the development of healthcare infrastructure and increased availability to pharmaceuticals. This expansion is expected to support continued growth in the pharmaceutical segment of the PAP market.
Supply chain disruptions
The para-aminophenol (PAP) market is severely challenged by supply chain interruptions, which can impair raw material availability, postpone manufacturing plans, and have an impact on distribution networks. Transportation of essential chemical precursors and final goods may be delayed by occurrences such as the COVID-19 pandemic, natural disasters, or geopolitical tensions. Increased lead times, greater operating expenses and perhaps fewer products available on the market are the results of these disruptions. Additionally, manufacturers might have trouble finding reliable sources of raw materials at affordable costs, which could affect their capacity to satisfy demand and stay profitable.
The COVID-19 pandemic disrupted the Para-Aminophenol (PAP) market by causing supply chain delays and temporary closures of manufacturing facilities, affecting production volumes. However, the demand for PAP in pharmaceutical applications, particularly for acetaminophen (paracetamol), surged as people sought over-the-counter medications for fever and pain relief. The pharmaceutical sector showed resilience, while the textile and dye industries faced slowdowns. Post-pandemic recovery is expected to drive steady growth in the PAP market.
The E-commerce segment is expected to be the largest during the forecast period
The E-commerce segment is expected to account for the largest market share during the forecast period driven by enabling easier access to raw materials for manufacturers and suppliers. Online platforms offer a convenient way for businesses to procure PAP for pharmaceutical, chemical, and cosmetic applications. E-commerce also facilitates direct transactions, reduces distribution costs, and widens the customer base, particularly for small and medium-sized enterprises, contributing to increased market accessibility and overall growth in the PAP industry.
The pharmaceuticals segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the pharmaceuticals segment is predicted to witness the highest growth rate due to the rising demand for acetaminophen (paracetamol), a widely used analgesic and antipyretic. As healthcare needs rise globally, especially in emerging markets, the demand for PAP to produce pain relief medications continues to increase. Additionally, advancements in healthcare infrastructure and expanding over-the-counter drug accessibility further boost the demand for PAP in the pharmaceutical industry.
During the forecast period, the Asia Pacific region is expected to hold the largest market share driven by rapid industrialization, growing pharmaceutical production, and expanding textile and cosmetic industries. The rising demand for acetaminophen in countries like China and India fuels the pharmaceutical sector, while the increasing use of PAP in dyes and pigments supports the textile and personal care industries. Moreover, cost-effective manufacturing and a large consumer base further contribute to the robust growth of the PAP market in this region.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, due to the growing demand for pain relievers and fever-reducing medications boosts PAP consumption. Additionally, North America's well-established pharmaceutical sector fosters market expansion, while increasing demand for advanced dyes in textiles and cosmetics further drives growth. This trend strengthens the region's influence in the global PAP market.
Key players in the market
Some of the key players in Para Aminophenol Market include BASF SE, Lanxess AG, Merck Group, Eastman Chemical Company, Sumitomo Chemical Co., Ltd., Hunan Lerk Pharmaceutical Co., Ltd., Aarti Industries Ltd., Arkema Group, Daiichi Sankyo Co., Ltd., Chongqing Changfeng Chemical Co., Ltd., Anhui Bayi Chemical Industry Co., Ltd., Jiangsu Huanxin Pharmaceutical Co., Ltd., Shandong Xinhua Pharmaceutical Co., Ltd., Lianyungang Dongjin Chemical Co., Ltd., and Taizhou Zhongtai Chemical Co., Ltd.
In January 2025, BASF's Personal Care business is launching a new ingredient, VitaGuard (R)A to capture the continuous market demand for retinol, while reinforcing its position as a Hero ingredient in cosmetics. This latest innovation is based on the encapsulation of free retinol. VitaGuard(R) A was developed using patented solid lipid particles, protecting retinol from degradation, limiting skin irritation and allowing better skin bioavailability for improved cosmetic efficacy.
In January 2025, Eastman introduced the latest innovation in its sustainable fiber portfolio today at Heimtextil trade fair in Frankfurt, Germany. Eastman Naia(TM) Renew cellulosic fiber for fill applications expands beyond the brand's success in bedding and towels. The fiber transforms comforters and quilts with breathable comfort, luxurious softness and unparalleled ease of care.